Understanding Why Skyland PIMS Was Selected - Novavax

Novavax has more than a decade of experience contending with some of the world’s most devastating diseases, including seasonal influenza, RSV, Ebola, MERS, and SARS

Headquartered in Gaithersburg, Maryland, Novavax is a late-stage biotechnology company that promotes improved global health through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. The company’s vaccine candidates are genetically engineered using three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis.

“ We needed to move fast on our COVID-19 vaccine, replace Excel data management, and accelerate CMO data sharing, PIMS was the perfect product. ” – Director of Data and Analytics, Novavax

Key points:

• Novavax wanted to harden its data infrastructure and discontinue wide-scale use of Excel for critical batch, process, and product data management
• With accelerated production timelines a key focal point, selecting a system that is easy to deploy, configure, and scale was high priority
• Advancing data sharing and collaboration among multiple CMO manufacturing sites worldwide was vital to expedite tech transfer and gain real-time operational oversight across the supply chain